Q1 2018 Holdings
Filed 2018-05-14 | 38 holdings | $673.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $56.1M | 3,321,173 | 8.3% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $51.6M | 1,305,887 | 7.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $44.6M | 2,380,846 | 6.6% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $41.7M | 1,539,822 | 6.2% |
| Zogenix Inc | COM NEW | 98978L204 | $39.2M | 978,302 | 5.8% |
| Spark Therapeutics Inc | COM | 84652J103 | $36.6M | 550,000 | 5.4% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $35.7M | 7,478,275 | 5.3% |
| Global Blood Therapeutics in | COM | 37890U108 | $35.6M | 736,631 | 5.3% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $34.0M | 500,000 | 5.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $33.2M | 400,000 | 4.9% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $30.4M | 8,579,454 | 4.5% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $28.7M | 900,579 | 4.3% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $24.5M | 4,781,708 | 3.6% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $19.9M | 899,900 | 3.0% |
| Prothena Corp PLC(PRTA)Call | SHS | G72800108 | $18.4M | 500,000 | 2.7% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $18.1M | 462,245 | 2.7% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $16.4M | 753,481 | 2.4% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $14.9M | 868,100 | 2.2% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $13.7M | 3,700,000 | 2.0% |
| Endocyte Inc | COM | 29269A102 | $13.6M | 1,491,500 | 2.0% |
| Corsicanto II Designated ACT | NOTE | 220485AB2 | $11.0M | 10,000,000 | 1.6% |
| Savara Inc(SVRA) | COM | 805111101 | $7.9M | 862,179 | 1.2% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $6.6M | 1,687,020 | 1.0% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $6.4M | 2,695,742 | 1.0% |
| Sierra Oncology Inc | COM | 82640U107 | $6.4M | 3,111,111 | 1.0% |
| PTC Therapeutics Inc(PTCT)Call | COM | 69366J200 | $5.4M | 200,000 | 0.8% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $5.2M | 309,800 | 0.8% |
| Acorda Therapeutics IncPut | COM | 00484M106 | $4.7M | 200,000 | 0.7% |
| Amarin Corp PLCCall | SPONS ADR NEW | 023111206 | $3.3M | 1,096,200 | 0.5% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $3.2M | 1,056,825 | 0.5% |
| Menlo Therapeutics Inc | COM | 586858102 | $2.0M | 52,008 | 0.3% |
| Newlink Genetics Corp | COM | 651511107 | $1.7M | 233,500 | 0.3% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $1.1M | 500,000 | 0.2% |
| Arena Pharmaceuticals Inc(ARNAEUR)Call | COM NEW | 040047607 | $604.0K | 15,300 | 0.1% |
| Acorda Therapeutics IncCall | COM | 00484M106 | $449.0K | 19,000 | 0.1% |
| Global Blood Therapeutics inPut | COM | 37890U108 | $275.0K | 5,700 | 0.0% |
| Streamline Health Solutions | COM | 86323X106 | $239.0K | 130,137 | 0.0% |